Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 192

1.

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.

Tausch E, Beck P, Schlenk RF, Jebaraj BJ, Dolnik A, Yosifov DY, Hillmen P, Offner F, Janssens A, Babu KG, Grosicki S, Mayer J, Panagiotidis P, McKeown A, Gupta IV, Skorupa A, Pallaud C, Bullinger L, Mertens D, Döhner H, Stilgenbauer S.

Haematologica. 2020 Jan 9. pii: haematol.2019.229161. doi: 10.3324/haematol.2019.229161. [Epub ahead of print]

2.

Regional analysis of UK primary care prescribing and adult service referrals for young people with attention-deficit hyperactivity disorder.

Price A, Ford T, Janssens A, Williams AJ, Newlove-Delgado T.

BJPsych Open. 2020 Jan 6;6(1):e7. doi: 10.1192/bjo.2019.94.

3.

In transition with ADHD: the role of information, in facilitating or impeding young people's transition into adult services.

Price A, Newlove-Delgado T, Eke H, Paul M, Young S, Ford T, Janssens A.

BMC Psychiatry. 2019 Dec 17;19(1):404. doi: 10.1186/s12888-019-2284-3.

4.

The Long Harm of Childhood: Childhood Exposure to Mortality and Subsequent Risk of Adult Mortality in Utah and The Netherlands.

van Dijk IK, Janssens A, Smith KR.

Eur J Popul. 2018 Nov 28;35(5):851-871. doi: 10.1007/s10680-018-9505-1. eCollection 2019 Dec.

5.
6.

Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy.

Van Meerbeeck JP, De Pooter C, Raskin J, Janssens A, Van Schil PE.

Curr Opin Oncol. 2020 Jan;32(1):54-62. doi: 10.1097/CCO.0000000000000596.

PMID:
31688138
7.

Clinician perspectives on the use of National Institute for Health and Care Excellence guidelines for the process of transition in Attention Deficit Hyperactivity Disorder.

Eke H, Janssens A, Newlove-Delgado T, Paul M, Price A, Young S, Ford T.

Child Care Health Dev. 2020 Jan;46(1):111-120. doi: 10.1111/cch.12718. Epub 2019 Dec 19.

PMID:
31613391
8.

Adolescent self-harm prevention and intervention in secondary schools: a survey of staff in England and Wales.

Evans R, Parker R, Russell AE, Mathews F, Ford T, Hewitt G, Scourfield J, Janssens A.

Child Adolesc Ment Health. 2019 Sep;24(3):230-238. doi: 10.1111/camh.12308. Epub 2018 Dec 5.

9.
10.

Comparison of IVIg 5% Versus 10% in hematological patients with a secondary immunodeficiency disorder.

Van Ham J, Janssens A, Raddoux J, Raets E, Delforge M.

Acta Clin Belg. 2019 Aug 17:1-4. doi: 10.1080/17843286.2019.1655860. [Epub ahead of print]

PMID:
31422766
11.

Seven steps to mapping health service provision: lessons learned from mapping services for adults with Attention-Deficit/Hyperactivity Disorder (ADHD) in the UK.

Price A, Janssens A, Dunn-Morua S, Eke H, Asherson P, Lloyd T, Ford T.

BMC Health Serv Res. 2019 Jul 9;19(1):468. doi: 10.1186/s12913-019-4287-7.

12.

Correction to: Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients.

Morscio J, Bittoun E, Volders N, Lurquin E, Wlodarska I, Gheysens O, Vandenberghe P, Verhoef G, Demaerel P, Dierickx D, Sagaert X, Janssens A, Tousseyn T.

J Hematop. 2018 May 4;11(2):65. doi: 10.1007/s12308-018-0323-5. eCollection 2018 Jun.

13.

Transition between child and adult services for young people with attention-deficit hyperactivity disorder (ADHD): findings from a British national surveillance study.

Eke H, Ford T, Newlove-Delgado T, Price A, Young S, Ani C, Sayal K, Lynn RM, Paul M, Janssens A.

Br J Psychiatry. 2019 Jun 4:1-7. doi: 10.1192/bjp.2019.131. [Epub ahead of print]

PMID:
31159893
14.

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia.

Steurer M, Montillo M, Scarfò L, Mauro FR, Andel J, Wildner S, Trentin L, Janssens A, Burgstaller S, Frömming A, Dümmler T, Riecke K, Baumann M, Beyer D, Vauléon S, Ghia P, Foà R, Caligaris-Cappio F, Gobbi M.

Haematologica. 2019 Oct;104(10):2053-2060. doi: 10.3324/haematol.2018.205930. Epub 2019 May 16.

15.

Ibrutinib Regimens in Older Patients with Untreated CLL.

Mercier T, Janssens A, Maertens J.

N Engl J Med. 2019 Apr 25;380(17):1679-1681. doi: 10.1056/NEJMc1901284. No abstract available.

PMID:
31018080
16.

Resumption of attention-deficit hyperactivity disorder medication in early adulthood: findings from a UK primary care prescribing study.

Newlove-Delgado T, Ford TJ, Hamilton W, Janssens A, Stein K, Ukoumunne OC.

Eur Child Adolesc Psychiatry. 2019 Dec;28(12):1589-1596. doi: 10.1007/s00787-019-01325-5. Epub 2019 Apr 4.

17.

Recruiting general practitioners for palliative care research in primary care: real-life barriers explained.

Leysen B, Van den Eynden B, Janssens A, Wens J.

BMC Fam Pract. 2019 Mar 5;20(1):40. doi: 10.1186/s12875-019-0930-y.

18.

Care experiences of young people with eating disorders and their parents: qualitative study.

Mitrofan O, Petkova H, Janssens A, Kelly J, Edwards E, Nicholls D, McNicholas F, Simic M, Eisler I, Ford T, Byford S.

BJPsych Open. 2019 Jan;5(1):e6. doi: 10.1192/bjo.2018.78.

19.

Overview and comparison of Legionella regulations worldwide.

Van Kenhove E, Dinne K, Janssens A, Laverge J.

Am J Infect Control. 2019 Aug;47(8):968-978. doi: 10.1016/j.ajic.2018.10.006. Epub 2019 Jan 9. Review.

PMID:
30638676
20.

Prognostic Understanding and Quality of Life in Patients With Advanced Lung Cancer: A Multicenter Study.

Janssens A, Derijcke S, Galdermans D, Daenen M, Surmont V, De Droogh E, Lefebure A, Saenen E, Vandenbroucke E, Morel AM, Sadowska A, van Meerbeeck JP.

Clin Lung Cancer. 2019 May;20(3):e369-e375. doi: 10.1016/j.cllc.2018.11.011. Epub 2018 Dec 13.

PMID:
30635259

Supplemental Content

Loading ...
Support Center